 |
|
|
|
|
|
|
ADA-SAP Module 1: Basic Principles of Management of Type 2 Diabetes
Module 1 of the American Diabetes Association Self-Assessment Program (ADA-SAP™) is a clinical problem-solving, evidence-based CME program of active engagement. It is designed to objectively assess and strengthen your knowledge of diabetes and provide you with a better understanding of the options available for managing patients with type 2 diabetes mellitus. You can complete this program at your own pace, whenever and wherever you choose.
Insulin and Oral Hypoglycemic Agents: Determining the Proper Combination
This Accredited Continuing Education Product comprises content captured live from
the American Diabetes Association 67th Scientific Sessions. This program will allow
Diabetes Healthcare Professionals to learn about the gap that exists between current
oral hypoglycemic and insulin treatment regimens and the attainment of optimal blood
glucose levels; the effectiveness of aggressive treatment regimens in helping patients
obtain their desired glycemic goals, especially with the use of innovative therapeutic
treatment options now available; and the methods for clinicians and patients to
receive the education needed to properly incorporate an aggressive therapeutic regimen
into a daily diabetes care plan.
Progressive Approaches in the Treatment of Type 2 Diabetes: Indications and Innovations
This Accredited Continuing Education Product comprises content captured live from
the American Diabetes Association 67th Scientific Sessions. This program will allow
Diabetes Healthcare Professionals to learn about the gap in current treatments of
type 2 diabetes; present and future therapies to correct incretin abnormalities;
research studies involving agents that are members of these innovative drug classes;
and the potential role of these innovative agents in the management of patients
with type 2 diabetes.
Diabetes and Antipsychotic Medications
The Diabetes and Antipsychotic Medications seminar and live multimedia Webcast events are designed specifically for psychiatrists, endocrinologists, primary care physicians, clinical psychologists, pharmacists, nurse practitioners, nurses and other interested health care professionals who treat patients with psychiatric illness, specifically schizophrenia.
DIABETES AND ITS CO-MORBIDITIES
The Diabetes and Its Co-Morbidities is a new series that will inform health care professionals of the most up-to-date methods of preventing and treating the complications of diabetes, particularly hypertension and chronic kidney disease. These one hour Webcasts will feature slide presentations followed by interactive Q&A sessions, which will allow health care professionals to receive feedback from experts.
These activities are developed specifically for internists, family practitioners, endocrinologists, diabetologists, physician assistants, nurses and nurse practitioners who treat patients with diabetes.
Prevention & Management of Chronic Kidney Disease in the Diabetes Patient
Diabetic nephropathy occurs in up to 40% of patients with diabetes and is characterized by proteinuria and progressive kidney failure. Diabetes is the leading cause of end-stage renal disease (ESRD), accounting for 40-50% of all cases. Intensive diabetes management focused on proper glucose control and lowering of hypertension has been shown to delay the onset of microalbuminuria and progression of nephropathy. This two-part Webcast series will present strategies to help health care professionals to successfully prevent and treat nephropathy.
Managing Hypertension in Adults with Diabetes
Hypertension is a common co-morbid condition of diabetes affecting the majority of people with diabetes. Hypertension is also a major risk factor for cardiovascular disease (CVD) and microvascular complication such as retinopathy and nephropathy. The Diabetes and Hypertension Webcast will help health care professionals to better treat their patients with diabetes and hypertension.
|
|
|
|
|
|
 |